Exact Sciences Corporatio... (EXAS)
NASDAQ: EXAS
· Real-Time Price · USD
54.59
1.45 (2.73%)
At close: Jul 01, 2025, 3:59 PM
54.60
0.02%
After-hours: Jul 01, 2025, 06:14 PM EDT
2.73% (1D)
| Bid | 53 |
| Market Cap | 10.3B |
| Revenue (ttm) | 2.83B |
| Net Income (ttm) | -1.02B |
| EPS (ttm) | -5.53 |
| PE Ratio (ttm) | -9.87 |
| Forward PE | 145.07 |
| Analyst | Buy |
| Ask | 54.62 |
| Volume | 2,300,148 |
| Avg. Volume (20D) | 3,416,820.6 |
| Open | 52.85 |
| Previous Close | 53.14 |
| Day's Range | 52.79 - 55.09 |
| 52-Week Range | 39.97 - 72.83 |
| Beta | 0.98 |
About EXAS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EXAS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EXAS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Exact Sciences Corporation is scheduled to release its earnings on Jul 30, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+9.31%
Exact Sciences shares are trading higher after the...
Unlock content with
Pro Subscription
2 months ago
+3.33%
Exact Sciences shares are trading higher after the company reported better-than-expected Q1 sales results and raised its FY25 sales guidance.
2 months ago · seekingalpha.com
Exact Sciences Q1 Earnings: Decent Quarter, But Growth Story Not CompellingExact Sciences Corporation posted solid Q1 2025 earnings with revenues up 11% year-on-year, driven by strong performance in screening and Precision Oncology segments. Despite the sequential revenue de...
